from those projected in such statements, including but not
limited to statements regarding the ultimate value of Westaim's
asset-backed commercial paper, the availability of credit, reduction of
operating costs, product development timelines and the work necessary for
the commercialization of iFire's technology, the potential of iFire's
technology, Westaim's financial resources, and the potential sale of iFire.
Westaim disclaims any intention or obligation to revise forward-looking
statements whether as a result of new information, future developments or
otherwise. Accordingly, readers are advised not to place undue reliance on
forward-looking statements, and should not rely on this information at any
date other than the date of this news release. All forward-looking
statements are expressly qualified in their entirety by this cautionary
statement.
THE WESTAIM CORPORATION
Financial Highlights
(unaudited)
(thousands of dollars except per share data)
-------------------------------------------------------------------------
Three Months Ended Nine Months Ended
September 30 September 30
Consolidated Statements --------------------- ---------------------
of Operations 2007 2006 2007 2006
-------------------------------------------------------------------------
Revenue $ 7,839 $ 8,203 $ 20,656 $ 22,451
Net loss (17,138) (9,552) (31,226) (39,538)
Net loss per common share
- basic and diluted (0.18) (0.10) (0.33) (0.42)
Weighted average number of
common shares outstanding
(thousands) 94,098 93,944 94,047 93,369
-------------------------------------------------------------------------
Th
'/>"/>
SOURCE Westaim Corporation Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related medicine news :1.
The Westaim Corporation update on status of short-term investments2.
Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results3.
HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness4.
CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael5.
UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West6.
HEI, Inc. Announces Sale of RFID Division Assets7.
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)8.
Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference9.
Z Trim Announces Revocation of Gregory Halpern Severence Agreement10.
Brooke Franchise Corporation Announces Selected July Results11.
Manor Care, Inc. Announces Record Date for Special Stockholder Meeting